New 13D15
New 13G168
Stated intents1
The week of 2026-01-20, 15 holders filed a new Schedule 13D and 168 a new Schedule 13G reporting 5% or more of a company, and 1 13D filing stated in Item 4 an intent to influence the company. Open a company for every holder and the purpose each 13D states, quoted.
New Schedule 13D
| Filed | Company | Holder | Percent | Filing |
|---|---|---|---|---|
| 2026-01-21 | Ecarx Holdings Inc. | Eric Li (Li Shufu) | 53.5% | SCHEDULE 13D |
| 2026-01-20 | T3 Defense Inc. | Menachem Shalom | 26% | SCHEDULE 13D |
| 2026-01-21 | Aurelion Inc. | Tether Global Investments Fund, S.I.C.A.F., S.A. | 21.5% | SCHEDULE 13D |
| 2026-01-23 | Infinite Eagle Acquisition Corp. | Eagle Equity Partners VI, LLC | 20.73% | SCHEDULE 13D |
| 2026-01-20 | BillionToOne, Inc. | Hummingbird Ventures Management NV | 19.6% | SCHEDULE 13D |
| 2026-01-20 | Aktis Oncology, Inc. | Mpm Bioventures 2018, L.P. | 19.3% | SCHEDULE 13D |
| 2026-01-21 | Founder Group Ltd | Lee Seng Chi | 18.8% | SCHEDULE 13D |
| 2026-01-20 | Gpgi Inc | Platinum Equity, LLC | 18.3% | SCHEDULE 13D |
| 2026-01-23 | Airwa Inc. | Hongyu Zhou | 13.8% | SCHEDULE 13D |
| 2026-01-20 | Aktis Oncology, Inc. | EcoR1 Capital, LLC | 9.1% | SCHEDULE 13D |
| 2026-01-21 | Health Catalyst, Inc. | Whetstone Capital Advisors, LLC intent stated | 7.4% | SCHEDULE 13D |
| 2026-01-20 | Trio Petroleum Corp | Robin A. Ross | 6% | SCHEDULE 13D |
| 2026-01-23 | Agenus Inc | Zynext Ventures Usa LLC | 5.9% | SCHEDULE 13D |
| 2026-01-22 | Gee Group Inc. | Star Equity Fund, LP | 5.4% | SCHEDULE 13D |
| 2026-01-23 | Battalion Oil Corporation | Diveroli Investment Group LLC | 5.39% | SCHEDULE 13D |
New Schedule 13G
| Filed | Company | Holder | Percent | Filing |
|---|---|---|---|---|
| 2026-01-20 | Starfighters Space, Inc. | Richard William Svetkoff | 65.2% | SCHEDULE 13G |
| 2026-01-22 | TCW Steel City Senior Lending BDC | Private Credit Fund C LP | 45.3% | SCHEDULE 13G |
| 2026-01-21 | Founder Group Ltd | Reservoir Link Energy Bhd | 23.16% | SCHEDULE 13G |
| 2026-01-23 | X3 Acquisition Corp. Ltd. | X3 Acquisition Management LLC | 22.3% | SCHEDULE 13G |
| 2026-01-20 | Auna S.A. | Grupo Angeles Servicios de Salud, S.A. de C.V. | 18.18% | SCHEDULE 13G |
| 2026-01-20 | Webuy Global Ltd | Guodong Xue | 17.33% | SCHEDULE 13G |
| 2026-01-20 | Intuitive Machines, Inc. | Advent International, L.P. | 16% | SCHEDULE 13G |
| 2026-01-22 | Terrestrial Energy Inc. | Roberto Marco Sella | 14.34% | SCHEDULE 13G |
| 2026-01-21 | Domo, Inc. | RPD Fund Management LLC | 11.9% | SCHEDULE 13G |
| 2026-01-21 | Infinity Natural Resources, Inc. | Chase Oil Corporation | 11.3% | SCHEDULE 13G |
| 2026-01-20 | Signing Day Sports, Inc. | L1 Capital Global Opportunities Master Fund, Ltd. | 9.99% | SCHEDULE 13G |
| 2026-01-22 | Super League Enterprise, Inc. | Empery Asset Management, LP | 9.99% | SCHEDULE 13G |
| 2026-01-22 | Precision Biosciences Inc | Empery Asset Management, LP | 9.99% | SCHEDULE 13G |
| 2026-01-23 | BriaCell Therapeutics Corp. | Kenneth Griffin | 9.99% | SCHEDULE 13G |
| 2026-01-22 | D. Boral ARC Acquisition I Corp. | Harraden Circle Investments, LLC | 9.93% | SCHEDULE 13G |
| 2026-01-20 | Biodexa Pharmaceuticals Plc | Sabby Management, LLC | 9.9% | SCHEDULE 13G |
| 2026-01-20 | InMed Pharmaceuticals Inc. | Sabby Management, LLC | 9.9% | SCHEDULE 13G |
| 2026-01-20 | Jiuzi Holdings, Inc. | Sabby Management, LLC | 9.9% | SCHEDULE 13G |
| 2026-01-20 | Lyra Therapeutics, Inc. | Sabby Management, LLC | 9.9% | SCHEDULE 13G |
| 2026-01-21 | Foxo Technologies Inc. | Sabby Management, LLC | 9.9% | SCHEDULE 13G |
| 2026-01-21 | Globavend Holdings Ltd | Sabby Management, LLC | 9.9% | SCHEDULE 13G |
| 2026-01-21 | Tempest Therapeutics, Inc. | Sabby Management, LLC | 9.9% | SCHEDULE 13G |
| 2026-01-21 | Oragenics Inc | Sabby Management, LLC | 9.9% | SCHEDULE 13G |
| 2026-01-21 | Brightspring Health Services Inc | BlackRock, Inc. | 9.9% | SCHEDULE 13G |
| 2026-01-21 | Marketaxess Holdings Inc | BlackRock, Inc. | 9.9% | SCHEDULE 13G |
| 2026-01-23 | Infinite Eagle Acquisition Corp. | Millennium Management LLC | 9.8% | SCHEDULE 13G |
| 2026-01-23 | Synlogic, Inc. | Baselake Partners, LP | 9.7% | SCHEDULE 13G |
| 2026-01-23 | Empery Digital Inc. | Brown, Tice | 9.7% | SCHEDULE 13G |
| 2026-01-20 | Revelation Biosciences, Inc. | Sabby Management, LLC | 9.6% | SCHEDULE 13G |
| 2026-01-21 | SciSparc Ltd. | L.I.A. Pure Capital Ltd. | 9.26% | SCHEDULE 13G |
| 2026-01-23 | OneIM Acquisition Corp. | Saba Capital Management, L.P. | 8.34% | SCHEDULE 13G |
| 2026-01-23 | Microbot Medical Inc. | Mitchell P. Kopin | 8.2% | SCHEDULE 13G |
| 2026-01-21 | WESCO International, Inc. | BlackRock Portfolio Management LLC | 8% | SCHEDULE 13G |
| 2026-01-23 | Gloo Holdings, Inc. | Dragonfly Trust | 7.98% | SCHEDULE 13G |
| 2026-01-21 | Ciena Corporation | Jpmorgan Chase & Co. | 7.7% | SCHEDULE 13G |
| 2026-01-21 | Orezone Gold Corp | Helikon Investments Limited | 7.55% | SCHEDULE 13G |
| 2026-01-22 | SAB Biotherapeutics, Inc. | Perceptive Advisors LLC | 7.3% | SCHEDULE 13G |
| 2026-01-21 | Sezzle Inc. | BlackRock, Inc. | 7.1% | SCHEDULE 13G |
| 2026-01-21 | Richtech Robotics Inc | BlackRock, Inc. | 7.1% | SCHEDULE 13G |
| 2026-01-21 | Crh Plc | BlackRock, Inc. | 6.9% | SCHEDULE 13G |
| 2026-01-21 | Qnity Electronics Inc | BlackRock, Inc. | 6.9% | SCHEDULE 13G |
| 2026-01-22 | Plus Therapeutics, Inc. | CVI Investments, Inc. | 6.9% | SCHEDULE 13G |
| 2026-01-21 | American Battery Technology Co | BlackRock, Inc. | 6.8% | SCHEDULE 13G |
| 2026-01-21 | iShares Enhanced Large Cap Core Active ETF | BlackRock Portfolio Management LLC | 6.8% | SCHEDULE 13G |
| 2026-01-21 | Lexeo Therapeutics, Inc. | BlackRock, Inc. | 6.7% | SCHEDULE 13G |
| 2026-01-20 | Big Tree Cloud Holdings Ltd | Sabby Management, LLC | 6.6% | SCHEDULE 13G |
| 2026-01-21 | Bentley Systems Inc | BlackRock, Inc. | 6.6% | SCHEDULE 13G |
| 2026-01-21 | Oruka Therapeutics, Inc. | BlackRock, Inc. | 6.6% | SCHEDULE 13G |
| 2026-01-21 | AXIA Energia S.A. | BlackRock, Inc. | 6.5% | SCHEDULE 13G |
| 2026-01-21 | iShares High Yield Active ETF | BlackRock Portfolio Management LLC | 6.5% | SCHEDULE 13G |
| 2026-01-22 | Innovative Eyewear, Inc. | Kelly Joseph Chapman | 6.41% | SCHEDULE 13G |
| 2026-01-20 | Forte Biosciences, Inc. | Point72 Asset Management, L.P. | 6.3% | SCHEDULE 13G |
| 2026-01-21 | LB Pharmaceuticals Inc. | Jpmorgan Chase & Co. | 6.3% | SCHEDULE 13G |
| 2026-01-21 | Tango Therapeutics, Inc. | BlackRock, Inc. | 6.3% | SCHEDULE 13G |
| 2026-01-21 | Lightbridge Corp | BlackRock, Inc. | 6.2% | SCHEDULE 13G |
| 2026-01-21 | UL Solutions Inc | BlackRock, Inc. | 6.2% | SCHEDULE 13G |
| 2026-01-20 | CAMPBELL'S Co | Contango Limited, LP | 6.18% | SCHEDULE 13G |
| 2026-01-20 | Adlai Nortye Ltd. | Unique Mark Ventures Ltd | 6.14% | SCHEDULE 13G |
| 2026-01-21 | iShares MSCI UAE ETF | BlackRock, Inc. | 6.1% | SCHEDULE 13G |
| 2026-01-20 | Andersen Group Inc. | Royce & Associates LP | 6.08% | SCHEDULE 13G |
| 2026-01-20 | Atlas Critical Minerals Corporation | Kenneth Griffin | 6% | SCHEDULE 13G |
| 2026-01-21 | iShares MSCI UAE ETF | BlackRock Portfolio Management LLC | 6% | SCHEDULE 13G |
| 2026-01-21 | Lemonade, Inc | Jpmorgan Chase & Co. | 5.9% | SCHEDULE 13G |
| 2026-01-21 | Ventas, Inc. | Jpmorgan Chase & Co. | 5.9% | SCHEDULE 13G |
| 2026-01-21 | Forge Global Holdings, Inc. | BlackRock, Inc. | 5.9% | SCHEDULE 13G |
| 2026-01-21 | iShares, Inc. | BlackRock Portfolio Management LLC | 5.9% | SCHEDULE 13G |
| 2026-01-23 | Repay Holdings Corporation | Forager Capital Management, LLC | 5.9% | SCHEDULE 13G |
| 2026-01-21 | Infinite Eagle Acquisition Corp. | Point72 Asset Management, L.P. | 5.8% | SCHEDULE 13G |
| 2026-01-20 | CAMPBELL'S Co | Consul FL LLC | 5.79% | SCHEDULE 13G |
| 2026-01-20 | Nayax Ltd. | Harel Insurance Investments & Financial Services Ltd | 5.7% | SCHEDULE 13G |
| 2026-01-21 | Ivanhoe Electric Inc | BlackRock, Inc. | 5.7% | SCHEDULE 13G |
| 2026-01-21 | Garrett Motion Inc | BlackRock, Inc. | 5.7% | SCHEDULE 13G |
| 2026-01-21 | Fortune Brands Innovations, Inc. | BlackRock Portfolio Management LLC | 5.7% | SCHEDULE 13G |
| 2026-01-21 | Foreign Trade Bank Of Latin America, Inc. | BlackRock, Inc. | 5.6% | SCHEDULE 13G |
| 2026-01-21 | Arrivent Biopharma Inc | BlackRock, Inc. | 5.6% | SCHEDULE 13G |
| 2026-01-21 | ORIC Pharmaceuticals, Inc. | BlackRock, Inc. | 5.6% | SCHEDULE 13G |
| 2026-01-21 | Ramaco Resources, Inc. | BlackRock, Inc. | 5.6% | SCHEDULE 13G |
| 2026-01-21 | Samsara Inc-Cl A | BlackRock, Inc. | 5.6% | SCHEDULE 13G |
| 2026-01-21 | Faraday Future Intelligent Electric Inc. | BlackRock, Inc. | 5.6% | SCHEDULE 13G |
| 2026-01-21 | Cushman And Wakefield Ltd | Dimensional Fund Advisors LP | 5.5% | SCHEDULE 13G |
| 2026-01-21 | Civeo Corp | Dimensional Fund Advisors LP | 5.5% | SCHEDULE 13G |
| 2026-01-21 | Celestica Inc | BlackRock, Inc. | 5.5% | SCHEDULE 13G |
| 2026-01-21 | iShares MSCI UAE ETF | BlackRock Portfolio Management LLC | 5.5% | SCHEDULE 13G |
| 2026-01-23 | Unicycive Therapeutics, Inc. | Integrated Core Strategies (US) LLC | 5.5% | SCHEDULE 13G |
| 2026-01-21 | Viant Technology Inc. | Royce & Associates LP | 5.47% | SCHEDULE 13G |
| 2026-01-21 | Solaris Resources Inc. | Helikon Investments Limited | 5.41% | SCHEDULE 13G |
| 2026-01-20 | Nuwellis, Inc. | Sabby Management, LLC | 5.4% | SCHEDULE 13G |
| 2026-01-21 | Kontoor Brands, Inc. | Jpmorgan Chase & Co. | 5.4% | SCHEDULE 13G |
| 2026-01-21 | Aegon Ltd. | BlackRock, Inc. | 5.4% | SCHEDULE 13G |
| 2026-01-21 | Savara Inc. | BlackRock, Inc. | 5.4% | SCHEDULE 13G |
| 2026-01-21 | Amalgamated Financial Corp. | BlackRock Portfolio Management LLC | 5.4% | SCHEDULE 13G |
| 2026-01-22 | Ranger Energy Services, Inc. | IES Holdings, Inc. | 5.4% | SCHEDULE 13G |
| 2026-01-23 | Kazia Therapeutics Ltd | Lynwood Capital Management Inc. | 5.4% | SCHEDULE 13G |
| 2026-01-21 | Talos Energy Inc. | Dimensional Fund Advisors LP | 5.3% | SCHEDULE 13G |
| 2026-01-21 | Grupo Televisa, S.A.B. | BlackRock, Inc. | 5.3% | SCHEDULE 13G |
| 2026-01-21 | Inhibrx Biosciences, Inc. | BlackRock, Inc. | 5.3% | SCHEDULE 13G |
| 2026-01-21 | Tss, Inc. | BlackRock, Inc. | 5.3% | SCHEDULE 13G |
| 2026-01-21 | IRSA Inversiones y Representaciones SA | Helikon Investments Limited | 5.25% | SCHEDULE 13G |
| 2026-01-20 | Stock Yards Bancorp, Inc. | Stock Yards Bank & Trust Co | 5.2% | SCHEDULE 13G |
| 2026-01-20 | ProQR Therapeutics NV | Privium Fund Management B.V. | 5.2% | SCHEDULE 13G |
| 2026-01-20 | Boston Omaha Corporation | 238 Plan Associates LLC | 5.2% | SCHEDULE 13G |
| 2026-01-20 | Vesta Real Estate Corporation, S.A.B. de C.V. | Norges Bank | 5.2% | SCHEDULE 13G |
| 2026-01-21 | Neurocrine Biosciences, Inc. | Jpmorgan Chase & Co. | 5.2% | SCHEDULE 13G |
| 2026-01-21 | Macerich Co | Jpmorgan Chase & Co. | 5.2% | SCHEDULE 13G |
| 2026-01-21 | Invesco Equal Weight 0-30 Year Treasury ETF | Truist Financial Corp | 5.2% | SCHEDULE 13G |
| 2026-01-21 | First Hawaiian Inc | Dimensional Fund Advisors LP | 5.2% | SCHEDULE 13G |
| 2026-01-21 | Forum Energy Technologies Inc | Dimensional Fund Advisors LP | 5.2% | SCHEDULE 13G |
| 2026-01-21 | MasterBrand, Inc. | Dimensional Fund Advisors LP | 5.2% | SCHEDULE 13G |
| 2026-01-21 | Helmerich & Payne Inc | Dimensional Fund Advisors LP | 5.2% | SCHEDULE 13G |
| 2026-01-21 | Niocorp Developments Ltd | BlackRock, Inc. | 5.2% | SCHEDULE 13G |
| 2026-01-21 | Bankwell Financial Group, Inc. | BlackRock, Inc. | 5.2% | SCHEDULE 13G |
| 2026-01-21 | Compass Therapeutics, Inc. | BlackRock, Inc. | 5.2% | SCHEDULE 13G |
| 2026-01-21 | Eagle Financial Services Inc | BlackRock, Inc. | 5.2% | SCHEDULE 13G |
| 2026-01-21 | First Capital Inc | BlackRock, Inc. | 5.2% | SCHEDULE 13G |
| 2026-01-21 | Hallador Energy Co | BlackRock, Inc. | 5.2% | SCHEDULE 13G |
| 2026-01-21 | Legalzoom.com Inc | BlackRock, Inc. | 5.2% | SCHEDULE 13G |
| 2026-01-21 | Mama's Creations Inc | BlackRock, Inc. | 5.2% | SCHEDULE 13G |
| 2026-01-21 | Marketwise, Inc. | BlackRock, Inc. | 5.2% | SCHEDULE 13G |
| 2026-01-21 | Black Rock Coffee Bar, Inc. | BlackRock, Inc. | 5.2% | SCHEDULE 13G |
| 2026-01-21 | Candel Therapeutics Inc | BlackRock, Inc. | 5.2% | SCHEDULE 13G |
| 2026-01-21 | Mineralys Therapeutics Inc | BlackRock, Inc. | 5.2% | SCHEDULE 13G |
| 2026-01-22 | iBio, Inc. | Integrated Core Strategies (US) LLC | 5.2% | SCHEDULE 13G |
| 2026-01-23 | Precigen, Inc. | Point72 Asset Management, L.P. | 5.2% | SCHEDULE 13G |
| 2026-01-23 | ASP Isotopes Inc. | Encompass Capital Advisors LLC | 5.13% | SCHEDULE 13G |
| 2026-01-21 | SoFi Technologies Inc | Jpmorgan Chase & Co. | 5.1% | SCHEDULE 13G |
| 2026-01-21 | BJs RESTAURANTS INC | Dimensional Fund Advisors LP | 5.1% | SCHEDULE 13G |
| 2026-01-21 | Carter Bankshares, Inc. | Dimensional Fund Advisors LP | 5.1% | SCHEDULE 13G |
| 2026-01-21 | Darling Ingredients Inc | Dimensional Fund Advisors LP | 5.1% | SCHEDULE 13G |
| 2026-01-21 | Mohawk Industries Inc | Dimensional Fund Advisors LP | 5.1% | SCHEDULE 13G |
| 2026-01-21 | Sun Country Airlines Holdings Inc | Dimensional Fund Advisors LP | 5.1% | SCHEDULE 13G |
| 2026-01-21 | Liberty Global Ltd. | BlackRock, Inc. | 5.1% | SCHEDULE 13G |
| 2026-01-21 | Cimpress plc | BlackRock, Inc. | 5.1% | SCHEDULE 13G |
| 2026-01-21 | Ericsson Lm Telephone Co | BlackRock, Inc. | 5.1% | SCHEDULE 13G |
| 2026-01-21 | Affirm Holdings, Inc. | BlackRock, Inc. | 5.1% | SCHEDULE 13G |
| 2026-01-21 | BRC Inc. | BlackRock, Inc. | 5.1% | SCHEDULE 13G |
| 2026-01-21 | Cb Financial Services Inc | BlackRock, Inc. | 5.1% | SCHEDULE 13G |
| 2026-01-21 | Charter Communications, Inc. | BlackRock, Inc. | 5.1% | SCHEDULE 13G |
| 2026-01-21 | First United Corp | BlackRock, Inc. | 5.1% | SCHEDULE 13G |
| 2026-01-21 | Inseego Corp | BlackRock, Inc. | 5.1% | SCHEDULE 13G |
| 2026-01-21 | LB Pharmaceuticals Inc. | BlackRock, Inc. | 5.1% | SCHEDULE 13G |
| 2026-01-21 | MBX Biosciences, Inc. | BlackRock, Inc. | 5.1% | SCHEDULE 13G |
| 2026-01-21 | ARS Pharmaceuticals, Inc. | BlackRock, Inc. | 5.1% | SCHEDULE 13G |
| 2026-01-21 | Strata Critical Medical, Inc. | BlackRock, Inc. | 5.1% | SCHEDULE 13G |
| 2026-01-21 | Cbl & Associates Properties Inc | BlackRock, Inc. | 5.1% | SCHEDULE 13G |
| 2026-01-21 | Franklin Financial Services Corp | BlackRock, Inc. | 5.1% | SCHEDULE 13G |
| 2026-01-21 | Lifecore Biomedical, Inc | BlackRock, Inc. | 5.1% | SCHEDULE 13G |
| 2026-01-21 | Koru Medical Systems Inc | BlackRock, Inc. | 5.1% | SCHEDULE 13G |
| 2026-01-21 | Sana Biotechnology, Inc. | BlackRock, Inc. | 5.1% | SCHEDULE 13G |
| 2026-01-21 | Toast Inc | BlackRock, Inc. | 5.1% | SCHEDULE 13G |
| 2026-01-21 | Rentokil Initial Plc | BlackRock Portfolio Management LLC | 5.1% | SCHEDULE 13G |
| 2026-01-22 | Genius Sports Ltd | Voss Capital, LP | 5.08% | SCHEDULE 13G |
| 2026-01-20 | Ennis, Inc. | Royce & Associates LP | 5.07% | SCHEDULE 13G |
| 2026-01-20 | Aviat Networks Inc | Royce & Associates LP | 5.05% | SCHEDULE 13G |
| 2026-01-21 | Stantec Inc | BlackRock, Inc. | 5.03% | SCHEDULE 13G |
| 2026-01-21 | Rapport Therapeutics, Inc. | BlackRock, Inc. | 5.03% | SCHEDULE 13G |
| 2026-01-21 | Cae Inc | BlackRock, Inc. | 5.02% | SCHEDULE 13G |
| 2026-01-21 | KKR & Co Inc | BlackRock, Inc. | 5.02% | SCHEDULE 13G |
| 2026-01-21 | Standard Motor Products Inc | Royce & Associates LP | 5.01% | SCHEDULE 13G |
| 2026-01-21 | Sight Sciences, Inc. | BlackRock, Inc. | 5.01% | SCHEDULE 13G |
| 2026-01-21 | Liberty Broadband Corp | BlackRock, Inc. | 5.01% | SCHEDULE 13G |
| 2026-01-21 | Entergy Corp | Jpmorgan Chase & Co. | 5% | SCHEDULE 13G |
| 2026-01-21 | Elanco Animal Health Inc | Dimensional Fund Advisors LP | 5% | SCHEDULE 13G |
| 2026-01-21 | Callaway Golf Company | Dimensional Fund Advisors LP | 5% | SCHEDULE 13G |
| 2026-01-21 | Zions Bancorp NA | Dimensional Fund Advisors LP | 5% | SCHEDULE 13G |
| 2026-01-21 | Trip.com Group Ltd | BlackRock, Inc. | 5% | SCHEDULE 13G |
| 2026-01-21 | Hippo Holdings Inc | BlackRock, Inc. | 5% | SCHEDULE 13G |
| 2026-01-21 | Peoples Bancorp Of North Carolina Inc | BlackRock, Inc. | 5% | SCHEDULE 13G |
| 2026-01-23 | Flushing Financial Corporation | Bay Pond Partners, L.P. | 5% | SCHEDULE 13G |
Stated intent
| Filed | Company | Holder | Percent | Filing |
|---|---|---|---|---|
| 2026-01-21 | Health Catalyst, Inc. | Whetstone Capital Advisors, LLC intent stated | 7.4% | SCHEDULE 13D |
Download this data (CSV)185 rows, with sources
Tools for this story
Each opens in a new tab. With no account yet, you sign up free and land on the result.
Where this comes from
Anyone who comes to own more than 5% of a class of a listed company's voting shares has to tell the SEC. A holder who may seek to change or influence the company files Schedule 13D, and has to say in Item 4, "Purpose of Transaction", what it intends to do. A holder with no such intent, such as many index and passive funds, may file the shorter Schedule 13G. Both are amended when the stake changes, including when it falls below 5%.
Every row here is one of those filings, linked to the filing itself. Percentages and share counts are exactly as the holder filed them, for the holder the filing names; an amendment showing a lower figure is shown as filed. Item 4 text is quoted word for word. Where a 13D's Item 4 contains a sentence stating a definite intent to influence the company, that sentence is marked and quoted; the page does not describe the holder or its motives beyond the words it filed. Nothing here is investment advice.